FDA Approves New Alzheimer’s Treatment
August 23, 2021
The first approval for a drug to treat Alzheimer’s since 2003 has recently been introduced under the trademark Aduhelmâ„¢ by the US Food and Drug Administration (FDA). The drug, Aducanumab, is a therapeutic drug that clinically demonstrates a potential to delay further decline from Alzheimer’s disease and is also the
